The 7 analysts offering 12-month price forecasts for Kindred Biosciences Inc have a median target of 11.00, with a high estimate of 16.00 and a low estimate of 9.00. The median estimate represents a +140.70% increase from the last price of 4.57.
The current consensus among 7 polled investment analysts is to Buy stock in Kindred Biosciences Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.30
Reporting Date Mar 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.